Loading...
•
Sep 30, 2024
OraSure Q3 2024 Earnings Report
OraSure's Q3 2024 financial performance reflected revenue of $39.9 million and GAAP EPS of $(0.06).
Key Takeaways
OraSure Technologies reported Q3 2024 revenue of $39.9 million, a 55% decrease compared to Q3 2023. Core revenues decreased by 1% year-over-year, while COVID-19 revenues declined significantly. The company is exiting its Risk Assessment testing business to focus on Diagnostics and Sample Management.
Q3 2024 revenue was $39.9 million, a 55% decrease year-over-year.
Core revenues decreased 1% year-over-year, with Diagnostics up 13% and Molecular Sample Management down 16%.
COVID-19 revenues decreased 96% year-over-year to $2.2 million.
The company is exiting the Risk Assessment testing business to focus on growth opportunities in Diagnostics and Sample Management.
Revenue by Segment
Forward Guidance
The Company is guiding to Q4 2024 revenues of $36 to $38 million. The Company anticipates Core revenues in Q4 2024 of $35 to $37 million, which includes $1 to $2 million of Risk Assessment testing revenues. The Company anticipates COVID-19 revenues in Q4 2024 of approximately $1 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...